GRAY, Tenn.--(BUSINESS WIRE)--PPA Research Group, a leading provider of diseased human hematologic tissue and cells for global life sciences, expands its business from the wholesale product market to retail markets worldwide. PPA Research Group is now offering customers a one stop solution for both healthy and diseased hematologic products. A newly redesigned website was established to help researchers find their product(s) of interest quickly and streamline the purchasing process.
During the last decade, PPA has served as a leading wholeseller of diseased human blood products for biotech and pharmaceutical companies through many strategic partners. “Research is constantly evolving and it is our mission to anticipate and meet our customers’ needs for high-quality tissues and cells. To keep pace with the demand for quality and efficiency in today’s market I believe it is essential to provide the opportunity for researchers to purchase both healthy and diseased hematologic products from one source,” said Kevin King, President and CEO of PPA Research Group.
Why use PPA?
- Our signature products are diseased Leukopacks, healthy Leukopacks, and healthy mobilized Leukopacks.
- Our one stop sourcing for healthy and diseased hematologic products allows researchers to rapidly fill their needs for their projects.
- We are committed to high product quality and competitive prices.
- Our strategic collection sites can recruit donors that are unique and specific for your research.
- Same day collection and isolation services provided.
For more information, we invite you to explore our newly redesigned website www.pparesearch.com.
PPA Research Group is a biotechnology company dedicated to providing global life sciences with the highest quality hematologic tissues and cells that enable drug discovery, stem cell research, and cellular therapeutics studies. We are specialized in tissue collections, hematology and immunology cell isolations using the gold standard in technology. PPA Research Group has a large donor pool that can meet various research applications. Our fresh hematologic cells are processed within a 1-3-hour timeframe after the tissue is collected to produce high quality and purified cell types. Our products are distributed worldwide. For more information, please visit www.pparesearch.com.